IP Library › Granted Patent US 12,335,692
Granted Patent B2
US 12,335,692 · App. 17/798,782 · Granted Jun 17, 2025

Implantable tinnitus therapy

Inventors: Thomas Leroux (Macquarie University, AU); Olivier Le Caharec (Macquarie University, AU)
Assignee: Cochlear Limited
H04R25/75A61N1/025A61N1/36036A61N1/36132
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,335,692
App. No.
17/798,782
Granted
Jun 17, 2025
Kind
B2
Abstract

Presented herein are techniques for providing tinnitus relief to recipients via an implantable arrangement. In accordance with embodiments presented herein, an implantable medical device, such as implantable tinnitus therapy device, auditory/hearing prosthesis, etc., comprises one or more implantable sensors configured to be implanted in a recipient. The one or more implantable sensors are configured to detect body noises of the recipient. The implantable medical device is configured to classify/categorize the one or more body noises and set, select, or otherwise determine a tinnitus therapy for the recipient based on the classification of the one or more body noises.

Claims (51)

1. A method, comprising:

detecting signals at one or more implantable sensors configured to be implanted in a recipient, wherein the signals comprise one or more body noises of the recipient;

generating, based on the one or more body noises, one or more body noise classifications;

generating tinnitus therapy signals based on the one or more body noise classifications; and

delivering the tinnitus therapy signals to the recipient.

2. The method of claim 1 , further comprising:

detecting, with the one or more implantable sensors, one or more external acoustic sounds with the one or more body noises;

generating, based on the one or more external acoustic sounds, one or more environmental classifications; and

generating the tinnitus therapy signals based on the one or more body noise classifications and based on the one or more environmental classifications.

3. The method of claim 2 , wherein generating the one or more body noise classifications comprises:

simultaneously generating two or more different classifications of the one or more body noises.

4. The method of claim 1 , wherein delivering the tinnitus therapy signals to the recipient comprises:

generating, with an implantable actuator, mechanical vibration signals based on the one or more body noise classifications; and

delivering the mechanical vibration signals to the recipient.

5. The method of claim 4 , wherein delivering the mechanical vibration signals to the recipient, comprises:

delivering the mechanical vibrations to an ossicular bone of the recipient.

6. The method of claim 4 , wherein delivering the mechanical vibration signals to the recipient, comprises:

delivering the mechanical vibration signals to a skull of the recipient.

7. The method of claim 1 , wherein delivering the tinnitus therapy signals to the recipient comprises:

generating electrical stimulation signals based on the one or more body noise classifications; and

delivering the electrical stimulation signals to the recipient via one or more electrodes configured to be implanted in the recipient.

8. The method of claim 1 , wherein generating the tinnitus therapy signals based on the one or more body noise classifications, comprises:

selecting, based on the one or more body noise classifications, a first tinnitus therapy map from among a plurality of predetermined tinnitus therapy maps.

9. The method of claim 1 , wherein the one or more body noise classifications indicate a current estimated behavior of the recipient.

10. The method of claim 1 , further comprising:

receiving a user input in response to delivery of the tinnitus therapy signals to the recipient, wherein the user input indicates a recipient adjustment to the tinnitus therapy signals; and

adjusting the tinnitus therapy signals based on the user input.

11. The method of claim 10 , further comprising:

performing an automated adaption process to adjust, based on the user input, future tinnitus therapy signals delivered to the recipient upon subsequent detection of the one or more body noise classifications.

12. The method of claim 10 , further comprising:

performing an automated adaption process to adjust tinnitus therapy signals delivered to the recipient upon subsequent detection of the one or more body noise classifications based on emotional reactions of the recipient to one or more tinnitus therapy signals.

13. The method of claim 11 , further comprising:

logging attributes of tinnitus therapy signals delivered to the recipient over a period of time; and

performing an automated adaption process to adjust tinnitus therapy signals delivered to the recipient upon subsequent detection of the one or more body noise classifications based on based on a time spent delivering tinnitus therapy signals to the recipient with particular attributes.

14. An apparatus, comprising:

one or more implantable sensors configured to be implanted in a recipient, wherein the one or more implantable sensors are configured to detect one or more body noises of the recipient;

a processing unit configured to:

generate, based on the one or more body noises, one or more body noise classifications, and

generate actuator control signals based on the one or more body noise classifications; and

an implantable actuator configured to deliver tinnitus therapy signals to the recipient based on the actuator control signals.

15. The apparatus of claim 14 , wherein the one or more implantable sensors are configured to detect one or more external acoustic sounds with the one or more body noises, and wherein the processing unit is configured to:

generate, based on the one or more external acoustic sounds, one or more environmental classifications; and

generating the actuator control signals based on the one or more body noise classifications and based on the one or more environmental classifications.

16. The apparatus of claim 14 , wherein to generate the one or more body noise classifications, the processing unit is configured to:

simultaneously generate two or more different classifications of the one or more body noises.

17. The apparatus of claim 14 , further comprising:

a memory configured to store a plurality of predetermined tinnitus therapy maps,

wherein to generate the actuator control signals, the processing unit is configured to select, based on the one or more body noise classifications, a first tinnitus therapy map from among the plurality of predetermined tinnitus therapy maps.

18. The apparatus of claim 14 , wherein the one or more body noise classifications indicate a current estimated behavior of the recipient.

19. The apparatus of claim 14 , wherein the processing unit is configured to receive a user input in response to delivery of the tinnitus therapy signals to the recipient, wherein the user input indicates a recipient adjustment to the tinnitus therapy signals, and wherein the processing unit is configured to adjust the tinnitus therapy signals based on the user input.

20. The apparatus of claim 19 , wherein the processing unit is configured to perform an automated adaption process to adjust, based on the user input, future tinnitus therapy signals delivered to the recipient in the presence of the one or more body noise classifications.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 11, 2022
From: LEROUX, THOMAS; LE CAHAREC, OLIVIER
To: COCHLEAR LIMITED
Reel/Frame 060780/0388 →
Continuity (2)
Provisional Application 62979501 · Feb 21, 2020
Related Publication 20230110745A1 · Apr 13, 2023
References Cited (19)
US 5795287A · Ballet al. · 1998 [cited by applicant]
US 6251062B1 · Leysieffer · 2001 [cited by applicant]
US 6565503B2 · Leysieffer et al. · 2003 [cited by applicant]
US 6575894B2 · Leysieffer et al. · 2003 [cited by applicant]
US 7442164B2 · Berrang et al. · 2008 [cited by applicant]
US 9143873B2 · Abolfathi · 2015 [cited by applicant]
US 10225671B2 · Goorevich et al. · 2019 [cited by applicant]
US 20070021804A1 · Maltan et al. · 2007 [cited by applicant]
US 20070203536A1 · Hochmair et al. · 2007 [cited by applicant]
US 20090270673A1 · Abolfath et al. · 2009 [cited by applicant]
US 20130039517A1 · Nielsen et al. · 2013 [cited by applicant]
US 20160094923A1 · Jensen et al. · 2016 [cited by applicant]
US 20160323683A1 · Pontoppidan · 2016 [cited by applicant]
US 20190054305A1 · Janssen et al. · 2019 [cited by applicant]
KR 101517143B1 · 2015 [cited by applicant]
KR 1020170129689A · 2017 [cited by applicant]
WO 2017213978A1 · 2017 [cited by applicant]
WO 2019161277A1 · 2019 [cited by applicant]
International Search Report and Written Opinion in counterpart International Application No. PCT/IB2021/050426, mailed Apr. 26, 2021, 10 pages. [cited by applicant]